The differential solvent extraction and further purification of fractions of endophytic Alternaria sp. isolated from Pinus ponderosa led to the isolation of further two perylenequinone compounds as 3,6,6a,9,10-pentahydroxy-7,8-epoxy-4-oxo-4,5,6,6a,6b,7,8,9-octahydroperylene (1) and 3,6,6a,7,10-pentahydroxy-4,9-dioxo-4,5,6,6a,6b,7,8,9-octahydroperylene (2). Structure of compounds 1e2 was determined on the basis of detailed spectroscopic analysis, as well as by comparison with literature reports. The antimicrobial, antileismanial, antimalarial and cytotoxic activities of compound 1 and 2 were evaluated.
Introduction
Perylenequinone natural products are generally dark coloured pigments isolated from diverse sources and have been used in different traditional herbal medicine through out the world. They comprise a family of natural products characterized by an oxidized pentacyclic core represented by parent perylenequinone. These vibrantly coloured natural products have the unique structural, biological and photochemical properties and have been extensively studied [1, 2] . In this article, we report further isolation of two perylenequinone compounds as 3,6,6a,9,10-pentahydroxy-7,8-epoxy-4-oxo-4,5,6,6a,6b,7,8,9-octahydroperylene (1) and 3,6,6a,7,10-pentahydroxy-4,9-dioxo-4,5,6,6a,6b,7,8,9-octahydroperylene (2) from endophytic Alternaria sp. isolated from Pinus ponderosa.
The compounds 1 (7.5 mg) and 2 (6.5 mg) were isolated from dichloromethane and ethylacetate extracts of the endophytic fungus (Alternaria sp.) respectively. Dichloromethane (200 mg) and ethylacetate (300 mg) residues were fractionated on open column chromatography [CHCl 3 , CHCl 3 -Methanol and MeOH, (silica gel 60e120, 70e230 mesh, Merck)], a solid phase extraction (SPE) (cartridge C-18 under vacuum), preparative TLC [CHCl 3 -MeOH (98:02)] and on preparative HPLC (Waters Ò Atlantis Ò 5m, C18 T3, 250 Â 19 mm column at a flow rate of 1 ml/ min). Isolation of compounds was scaled up on preparative HPLC using a flow rate of 15 ml/min. The solvent system was first developed at analytical HPLC and the same was adopted on preparative HPLC. The isolated compounds 1 and 2
were evaluated for antileismanial, antimicrobial, antimalarial and cytotoxic activities.
Material and methods

General
Optical rotations were recorded using a Rudolph Research Analytical Autopol V polarimeter. UV was obtained using a Perkin-Elmer Lambda 3B UV/Vis spectro- and silica gel (70e230 mesh, Merck) were used for column chromatography.
Fractions from column chromatography were monitored using TLC, silica gel F 254 , preparative TLC was carried out on silica gel 60 PF 254 þ 60366 plates (20 Â 20 cm, 1 mm thick). Visualization of the TLC plates was achieved with a UV lamp (l ¼ 254 and 365 nm) and p-anisaldehyde/acid spray reagent (methanol-acetic acidanisaldehyde-sulfuric acid, 85:9:1:5). Chemicals used were from Sigma-Aldrich (Poole, Dorset, U.K.), HPLC solvents were HPLC grades and were purchased from Sigma-Aldrich.
Preparation of endophytic fungus and its cultivation
DC401 (Alternaria sp.) was inoculated onto potato dextrose agar (PDA) at room temperature (w25e30 C) for two weeks with daily growth monitoring, followed by inoculation onto potato dextrose broth with shaking at 160 rpm for 14 days at 30 C. After 14 th day, the cultures were first filtered through sterile cotton using vacuum filtration; activated Dianion HP-20 was added to each flask and was returned to the shakers for another day. HP-20 was collected and washed with methanol then acetone. Methanol and acetone were combined and evaporated to dryness using a Buchi Rotavapor R-200. After evaporating all organic solvent, the remaining residue contained some portion of water (liquid-liquid extraction). The fungi strain (DC401) was grown on Potato Dextrose Agar (PDA) plates at a room temperature w28 C for 14 days with daily growth monitoring. Plates were kept in refrigerator and used when needed. For small scale extractions, the fungi were grown on small scale using Potato Dextrose Broth (PDB, Sigma-Aldrich Chemie). PDB media was prepared by dissolving 24 g of PDB in 1L distilled water and autoclaved. 50 ml of PDB was placed in 125 ml conical flasks and incubated with small pieces of actively growing mycelium. The cultures were incubated at 30 C under orbital agitation (160 rpm) for 14 days. After incubation, the contents of the flasks were filtered through sterile cotton using vacuum filtration and then the filtrates were extracted exhaustively with ethylacetate. The organic phase was vacuum concentrated to obtain the extracts. The extracts were sent to biological assays. For large scale extractions, 1L of PDB placed in 2800 ml Fernbach flasks were autoclaved and incubated with small pieces of actively growing mycelium. The cultures were incubated at 30 C under orbital agitation (160 rpm) for 14 days. After incubation, the contents of the flasks were filtered through sterile cotton using vacuum filtration. After filtration 100 g activated ion exchange resin (Diaion-HP20) was added to each 1L of filtrates. It was returned to shakers and left overnight. After that it was filtrated and HP20 was washed with water, methanol, and then acetone. Methanol and acetone were combined and dried under vacuum. The residue was dissolved in water and extracted with hexane, dichloromethane, and ethylacetate respectively.
Extraction and isolation
Compounds 1 (7.5 mg) and 2 (6.5 mg) were isolated from dichloromethane and ethylacetate fractions respectively. Dichloromethane (200 mg) fraction was fractioned using a solid phase extraction (SPE) cartridge C-18 under vacuum. Four fractions were obtained (F1-F4). Fraction 4 (F4) was subjected to open column chromatography using chloroform, CHCl 3 -Methanol and MeOH, (silica gel 60, 70e230 mesh, Merck), which yielded several sub0fractions (F4a-d). Fraction F4d was chromatographed using preparative TLC with CHCl 3 -MeOH (90:10) three runs, affording compounds 1 (7.5 mg). The ethylacetate (300 mg) fraction was chromatographed using C-18 SPE cartridge under negative pressure, giving twelve fractions (F1-F12). Fractions 8, 9, and 10 were combined and purified by HPLC to obtain compound 2 (6.5 mg) again using a Waters Ò Atlantis Ò 5m, C18 T3, 250 Â 4.6 mm column an isocratic for 5 min 100% water þ 0.1% formic acid (FA), then a gradient from 100% water þ 0.1% FA to 100% MeCN þ 0.1% FA at a flow rate of 1.5 ml/min over another 75 min time. It was scaled up on preparative HPLC using a Waters Ò Atlantis Ò 5m, C18 T3, 250 Â 19 mm column at a flow rate of 25.5 ml/min with the same solvent system that was used on analytical HPLC method. 
Antileishmanial assay
The antileishmanial activity of the crude extracts/fractions/or pure compounds was measured in-vitro against a culture of Leishmania donovani promastigotes. Compounds tested were added to the Leishmania promastigotes or the axenic amastigotes cultures containing 2 Â 10 6 cells/ml. The plates were incubated at 26 C for 72 hours and the growth of Leishmania promastigotes/axenic amastigotes was determined using AlamarBlueÒ Assay. Pentamidine and amphotericin B were used as the positive controls. IC 50 and IC 90 values were computed from the dose-response curves.
Antimalarial assay
Antimalarial activity was determined in-vitro against chloroquine sensitive (D6, Sierra Leone) and resistant (W2, Indo China) strains of Plasmodium falciparum. The assay is based on evaluation of the effect of the test compounds on the growth of cultures of Plasmodium falciparum and determined by the assay of plasmodial lactate dehydrogenase (LDH) activity. The test compounds were dissolved in DMSO (2 mg/ml). A 200 ml suspension of Plasmodium falciparumculture (2% parasitemia and 2% hematocrit in RPMI 1640 medium supplemented with 10% human serum and 60 mg/mL amikacin) was added to the wells of a 96-well plate containing 10 mL of serially diluted samples. The plates were put in a humidified chamber and flushed with a gas mixture of 90% N 2 , 5% O 2 , and 5% CO 2 and incubated at 37 C for 72 hours. Plasmodial LDH activity was determined by using MalstatÔ reagent (Flow Inc., Portland, OR). Briefly, 100 mL of the Malstat reagent was added to 20 mL of the incubation mixture and incubated for 30 min. After that, 20 mL of a 1:1 mixture of NBT/PES (Sigma, St. Louis, MO) was added and the plate was further incubated for 1 h in dark. The reaction was stopped by adding 100 mL of a 5% acetic acid solution. The plate was measured at 650 nm using the EL-340 Biokinetics
Reader (Bio-Tek Instruments, Vermont). The primary screening of the crude extracts/fractions was run at a single concentration 15 mg/ml only on chloroquine sensitive (D6) strain of P. falciparum. The extracts showing !50% inhibition in the growth of the parasite were tested at three concentrations in the secondary screening.
Chloroquine and artemisinin were included in each assay as the positive controls while DMSO (0.25%) was used as the negative control. IC 50 values were obtained from the dose-response curves generated by plotting percent growth versus concentrations of tested compounds.
In-vitro cytotoxicity assay
The cytotoxicity of compounds was determined against mammalian kidney fibro- 3. Results and discussion
Structure identification
As a part of our programme to work out phytochemically on endophytic fungi, for a continuous chase for bioactive as well as structurally different molecules, we further fractionated the fungus (Alternaria sp.) and isolated two new perylenequinones 1 and 2.
The compound 1 depicted molecular ion peak at 369.0954 [M þ H] þ in the positive ESI-MS. The molecule was again analyzed as through the fragments A -D illustrated in our already published article [4] . The 13 C NMR showed 20 resonances corresponding to the 20 carbons, which in DEPT spectra further revealed the presence of one methylene at d C 37. Based on the above discussion structure 1 was assigned to compound 1. The positions of carbonyl, hydroxyl and epoxide were supported by HMBC, HMQC and H-H COSY 2D NMR experiments (Fig. 2) . The compound 1 was finally elucidated to be 3,6,6a,9,10-pentahydroxy-7,8-epoxy-4-oxo-4,5,6,6a,6b,7,8,9-octahydroperylene (Fig. 1) .
The compound 2 showed the molecular ion peak at 369.0878 to -C-OH (C-7) and eCH 2 (C-8) and an oxidized carbonyl at C-9 (d C 203.0). These assignments were further supported by HMBC and HMBC NMR experiments (Fig. 2) . Based on this compound 2 was elucidated to be 3,6,6a,7,10-pentahydroxy-4,9-dioxo-4,5,6,6a,6b,7,8,9-octahydroperylene ( Fig. 1 ).
Biological evaluation
Compound 1 showed antileishmanial activity against Leishmania donovani with IC 50 ¼ 2.55 mg/ml and IC 90 ¼ 8.28 mg/ml. Compound 2 showed antileishmanial activity against Leishmania donovani with IC 50 ¼ 4.40 mg/ml and IC 90 ¼ 9.54 mg/ml and antimalarial activity against both the chloroquine sensitive (D6) and chloroquine resistant (W2) clones of P. falciparum with IC 50 ¼ 4.24 mg/ml and 3.65 mg/ml respectively and cytotoxicity activity against mammalian kidney fibroblasts (VERO cells) with IC 50 ¼ 3.59 mg/ml.
Plausible biosynthesis of perylenequinones and subsequent isomerisation
Compounds 1 and 2 are examples of reduced perylenequinones so far identified in fungi. The biosynthesis of these compounds occurs most probably via oxidative coupling of two molecules of a tetralone derivative synthesized from a pentaketide derivative by head to head coupling, followed by reduction and hydroxylation in different positions. The plausible biosynthetic pathway of reduced perylenequinones 1 and 2 and possible isomerization is shown in figure (Fig. 3) .
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